NCT06438939View on ClinicalTrials.gov

NBI for Early Diagnosis of OPMD/OSCC

NANot yet recruitingINTERVENTIONAL

Enrollment

480

Participants

Timeline

Start Date

September 30, 2024

Primary Completion Date

August 31, 2026

Study Completion Date

December 31, 2026

Conditions

Oral Squamous Cell CarcinomaOral Potentially Malignant Disorder

Interventions

OTHER

Biopsy for diagnostical purposes

Incisional biopsy is the current golden standard for OPMD/OSCC diagnosis. Yet, the site it shall be performed is choosen by clinician at naked eyes. We will compare and study the results of performing the common golden standard biopsy site when guided by NBI.

Trial Locations (1)

80131

Agostino Guida, Napoli

All Listed Sponsors

lead

Cardarelli Hospital

OTHER

NCT06438939 - NBI for Early Diagnosis of OPMD/OSCC | Biotech Hunter | Biotech Hunter